Evidence map›Paper›PMID 23768494›Full record

ArticleCell host & microbe2013

Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection.

Daniel Rubio, Ren-Huan Xu, Sanda Remakus, Tracy E Krouse, Mary Ellen Truckenmiller, Roshan J Thapa, Siddharth Balachandran, Antonio Alcamí, Christopher C Norbury, Luis J Sigal

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The roles of CD4Molecular therapy. Nucleic acids · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Daniel RubioImmune Cell Development and Host Defense Program, Research Institute of Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Ren-Huan Xu
Sanda Remakus
Tracy E Krouse
Mary Ellen Truckenmiller
Roshan J Thapa
Siddharth Balachandran
Antonio Alcamí
Christopher C Norbury
Luis J Sigal
Fox Chase Cancer Center · USPennsylvania State University · USCentro de Biología Molecular Severo Ochoa · ESConsejo Superior de Investigaciones Científicas · ES

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
The innate Immune Response to Mousepox at the Site - Associated ProjectU19AI083008 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI SIGAL, LUIS J · 2009 to 2013
$9.6M
Orthropoxvirus Pathogenesis and VaccinesR01AI065544 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SIGAL, LUIS J · 2006 to 2016
$5.7M
NCI NIH HHS CA006927NCI NIH HHS P30 CA006927NCI NIH HHS T32 CA009035NIAID NIH HHS R01 AI065544NIAID NIH HHS R01AI065544NIAID NIH HHS U19 AI083008NIAID NIH HHS U19AI083008
6 · The paper itself

Abstract

Nuclear factor kappa B (NF-κB) and type 1 interferon (T1-IFN) signaling are innate immune mechanisms activated upon viral infection. However, the role of NF-κB and its interplay with T1-IFN in antiviral immunity is poorly understood. We show that NF-κB is essential for resistance to ectromelia virus (ECTV), a mouse orthopoxvirus related to the virus causing human smallpox. Additionally, an ECTV mutant lacking an NF-κB inhibitor activates NF-κB more effectively in vivo, resulting in increased proinflammatory molecule transcription in uninfected cells and organs and decreased viral replication. Unexpectedly, NF-κB activation compensates for genetic defects in the T1-IFN pathway, such as a deficiency in the IRF7 transcription factor, resulting in virus control. Thus, overlap between the T1-IFN and NF-κB pathways allows the host to overcome genetic or pathogen-induced deficiencies in T1-IFN and survive an otherwise lethal poxvirus infection. These findings may also explain why some pathogens target both pathways to cause disease.

Indexed as

Signal TransductionAnimalsEctromelia, InfectiousEctromelia virusImmunity, InnateInterferon Type IMiceNF-kappa BInterferon Type INF-kappa B

Identifiers

PMID23768494
PMCPMC3688842
OpenAlexW2039142775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.